Inactive Instrument
Quotes GENFIT Euronext Paris
Stocks
FR0004163111
Biotechnology & Medical Research
|
End-of-day quote
Euronext Paris
|
||
| - EUR | - |
|
| 09-15 | French and Benelux stocks-Factors to watch on September 15 | RE |
| 09-15 | France's Genfit Plans Phase 2a Trial of Liver Failure Treatment | MT |
Stock exchange
Euronext Paris- €
-
0
€
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
| GNFT | 8.920EUR | -1.44% | 8.17M € | ||
CBOE
| GNFTp | 8.900EUR | -2.52% | 1.88M € | |
Börse Stuttgart
| XUP | 8.910EUR | -1.98% | 315K € | |
Xetra
| XUP | 10.52EUR | -0.38% | 15.91K € | |
London S.E.
| 0QT6 | 8.850EUR | -1.72% | 8.85K € | |
Tradegate
| XUP | 8.980EUR | -1.97% | 4.35K € | |
OTC Markets
| GNFTF | 15.75USD | -3.26% | 6.14K $ | |
CBOE
| 0QT6 | 8.750EUR | -16.27% | 498.75 € | |
Boerse Muenchen
| XUP | 8.840EUR | -3.81% | 300.56 € | |
Deutsche Boerse AG
| XUP | 9.020EUR | -10.52% | 0 € |
Basic data
Market Cap (EUR)
446,216,069
Market Cap (USD)
508,508,341
Net sales (EUR)
71,115,000
Net sales (USD)
81,042,735
Free-Float
86.89%
Free-Float capitalization (EUR)
387,820,816
Free-Float capitalization (USD)
441,961,044
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| - | 0.00% | - | - | 509M | ||
| -0.14% | +4.33% | +9.00% | +31.64% | 47.97B | ||
| -1.69% | +1.48% | +50.57% | +34.53% | 44.5B | ||
| +2.56% | +7.34% | +366.69% | +608.26% | 43.93B | ||
| +0.24% | +2.85% | +10.67% | +94.47% | 41.03B | ||
| -0.62% | -1.11% | +4.65% | +48.91% | 29.85B | ||
| -0.28% | +1.07% | +24.58% | +155.58% | 17.27B | ||
| +3.37% | +9.21% | +8.32% | - | 15.34B | ||
| -0.46% | +1.20% | +26.90% | +42.21% | 15.3B | ||
| -2.21% | -4.70% | - | - | 14.82B | ||
| Average | +0.09% | +2.35% | +62.67% | +145.08% | 27.05B | |
| Weighted average by Cap. | +0.11% | +2.86% | +79.67% | +160.28% |
Historical Quotes: GENFIT
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Price Extremes
- Stock Market
- Stocks
- GNFT Stock
- Stock
- Quotes GENFIT
Select your edition
All financial news and data tailored to specific country editions

















